quinazolines has been researched along with apelin-13 peptide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, HN; Chueh, HY; Pang, JS; Yeh, YC | 1 |
1 other study(ies) available for quinazolines and apelin-13 peptide
| Article | Year |
|---|---|
The anti-angiogenic effect of tryptanthrin is mediated by the inhibition of apelin promoter activity and shortened mRNA half-life in human vascular endothelial cells.
Topics: Angiogenesis Inhibitors; Apelin; Apelin Receptors; Flavonoids; Gene Expression Regulation; Half-Life; Human Umbilical Vein Endothelial Cells; Humans; Intercellular Signaling Peptides and Proteins; Promoter Regions, Genetic; Quinazolines; RNA Stability; RNA, Messenger; Signal Transduction; Wortmannin | 2019 |